エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-43304
OPTIMI HEALTH CORP.
269 David Brown Way
Princeton, B.C. V0X 1W0
Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXHIBIT INDEX
|
Exhibit |
Description of Exhibit |
|
| 99.1 | SEDI Report Statement |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| OPTIMI HEALTH CORP. | |||
| Date: August 6, 2026 | By: | /s/ Dane Stevens | |
| Name: | Dane Stevens | ||
| Title: | Chief Executive Officer, Chief Marketing Officer and Director | ||
Exhibit 99.1
Optimi Health Corp. (Nasdaq: OPTH) reports the open market purchase of 3,800 common shares of Optimi Health Corp. at CDN$6.70 by Dane Stevens, Chief Executive Officer of Optimi Health Corp. The purchase was made indirectly through Cathay Visions Enterprises Ltd., a company controlled by Mr. Stevens. on August 5, 2026. Following the transaction, Mr. Stevens beneficially holds 456,347 common shares of Optimi Health Corp.